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 Abstract: The collection of different bulk materials forms the nanoparticles, where the properties of the 
nanoparticle are solely different from the individual components before being ensembled. Self-
assembled nanoparticles are basically a group of complex functional units that are formed by  gathering 
the individual bulk components of the system. It includes micelles, polymeric nanoparticle, carbon nano-
tubes, liposomes and niosomes, etc. This self-assembly has progressively heightened interest to control 
the final complex structure of the nanoparticle and its associated properties. The main challenge of for-
mulating self-assembled nanoparticle is to improve the delivery system, bioavailability, enhance circula-
tion time, confer molecular targeting, controlled release, protection of the incorporated drug from exter-
nal environment and also serve as nanocarriers for macromolecules. Ultimately, these self-assembled 
nanoparticles facilitate to overcome the physiological barriers in vivo. Self-assembly is an equilibrium 
process where both individual and assembled components are subsisting in equilibrium. It is a bottom up 
approach in which molecules are assembled spontaneously, non-covalently into a stable and well-
defined structure. There are different approaches that have been adopted in fabrication of self-assembled 
nanoparticles by the researchers. The current review is enriched with strategies for nanoparticle self-
assembly, associated properties, and its application in therapy. 
A R T I C L E  H I S T O R Y 
Received: June 11, 2019 
Revised: September 28, 2019 




Keywords: Self-assembly, driving forces, nanoparticle, mesoporous silica nanoparticle, gold nanoparticle, liposome. 
1. INTRODUCTION 
 In the current field of pharmaceutical research, nanopar-
ticular drug delivery system has established itself as a prom-
ising tool in nanotechnology, where the nanoscale formula-
tion can lead to a potential increase in delivery efficiency [1–
3]. Development of nanoparticular delivery has been extended 
towards the delivery of chemotherapeutics to obtain superior 
efficacy with reduced toxicity of the cytotoxic drugs [1,4]. 
These modern delivery systems overcome the boundaries of 
larger biodistribution, unfavourable pharmacokinetics, and 
unfavourable physicochemical properties [5, 6]. Mechanisms 
of absorption for the nanoparticular deliveries into the site of 
disease action, through an endocytotic pathway either by  
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specific mechanisms (like receptor-mediated endocytosis) or 
by non-specific interactions (like adsorptive endocytosis 
with cell membranes) overcome the intracellular barriers,like 
endosomes and thus directly delivers the therapeutics into 
the cytosol for the desired pharmacological action [7, 8]. To 
avoid undesired toxicities, mainly of chemotherapeutics, 
these nanocarriers can be targeted with specific ligands on 
the surface towards disease specific sites by size-dependent 
passive or active targeting [9,10]. Alternatively, these nano-
particular deliveries can penetrate well into the tissues due to 
their nano-ranged size and thus, can be administrated intra-
venously with less irritation at the injection site[11]. 
 Nowadays, spontaneous organisation of the discrete 
components of nanoparticles provides a platform for poten-
tial biomedical and pharmaceutical applications [12, 13]. 
Such microscopic ordered organisation of components or 
self-assembly is characteristically associated with thermody-
namic equilibrium with the advantages of improving bioa-
vailability of poor bioavailable therapeutics, targetability to 
the disease site, controlled release for extended action, en-
hanced circulation time, provide protection to the drug from 
the external environment, serving as carriers for macromole-
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cules like proteins, peptides, nucleic acids, hydrophilic and 
lipophilic drugs. In the present scenario, various self-
assembly nanostructures have been synthesized from bio-
materials such as carbohydrates, nucleic acids, peptides, etc., 
for their biomedical as well as pharmaceutical applications 
[14–17]. Colloidal based drug delivery systems provide con-
trolled delivery as well as targeted drug delivery at the site of 
cell. Drug targeting with nano-based technology will enable 
targeting of drug to a specific site, in short controlling the 
fate of drug in biological system. Advantage over conven-
tional therapy is their effective uptake by cells. Another ad-
vantage of conventional therapy is that nanosystems can be 
developed according to biological interactions with system, 
targeting cell-surface receptors, targeting specific cell popu-
lation, controlling the drug release at site, maintaining the 
therapeutic concentration of drug at the site. The present 
review provides an overview of different methods, interac-
tions and recent development on nanoparticle self-assembly 
with the current advancements in technological applications. 
1.1. Self-assembly 
 Self-assembled nanostructured constituents are frequent-
ly stimulated by nature as most of our biological structures 
are the product of self-assembly. The conventional method 
of fabrication for the drug delivery tools involves a series of 
chemical reactions between chemical molecules, and further 
to modify with targeting moiety, ligands are conjugated with 
the colloidal nanocarriers. Recent advancement in nanotech-
nology leads towards the development of self-assembled 
nanostructured systems. Programmable self-assembly of 
molecular building blocks is an extremely necessary means 
of accomplishing bottom-up control over novel functions and 
materials. The intermolecular interactions between the drug 
and ligands in self-assembled drug delivery tool does not 
impact on its inherent activities [18]. This assembling ap-
proach for the pharmaceuticals cuts the purification stage(s) 
of the final products, and also removes unwanted reactants 
and their by-products [19]. Basically, self-assembly is a bot-
tom-up process, generally in which reactant molecules spon-
taneously, and/or non-covalently assemble into a well-
defined and stable nanostructure due to direct specific inter-
actions and/or indirectly, through their environment [20]. 
Alternatively, thermodynamics and other limitations like 
energy, entropy, templates (surface-modified substrates, con-
taining active sites, which can selectively induce nanoparti-
cle deposition), applied external fields to some extent con-
trols the self-assembly. Among the above-mentioned factors, 
templates and applied fields aids directed self-assembly. In-
terfacial or surface tension forces that are acting on the inter-
faces leading to directed self-assembly [21]. It is a balanced 
process that maintains equilibrium between repulsive and 
attractive forces between molecules (Fig. 1).  
 The thermodynamics of the self-assembly process can be 
represented by a simple Gibbs Free-Energy equation. 
ΔGSA =ΔHSA - TΔSSA 
 Gibbs free energy is available in the system; it is collec-
tively termed as the addition of enthalpy (ΔH) and the multi-
plication of temperature (T) and entropy (ΔS) of the system. 
The value of (ΔG) is always negative as it represents the 
spontaneous reaction occurring in the system (means no re-
quirement of superficial energy input) and if the value is 
positive, then the reaction occurrence is nonspontaneous 
(means superficial energy is important for reaction).  
• ΔG < 0: reaction is exergonic 
• ΔG = 0: system is in equilibrium 
• ΔG > 0: reaction is endergonic  
 Most self-assembly processes are enthalpy driven but in 
certain cases, it is entropy driven [22]. 
 
Fig. (1). Self-assembly of nanoparticles. 
2. DRIVING FORCES FOR SELF-ASSEMBLY OF 
NANOSTRUCTURES 
 As discussed above, self-assembly is a balanced process 
in which well-defined arrangements are spontaneously 
formed from building blocks. Driving force is termed as the 
affinity of the system to attain thermodynamic stability, 
which means it is  similar to the chemical potential of same 
molecule in dissimilar supramolecular system. The driving 
force is explained by equation: combined 








!°Ν  = mean value of free energy of molecule 
ΧΝ
= concentration  of  combined  supramolecular  compound. 
 The most important forces that drive self-assembly are 
non-covalent interactions that include Vander-Waals interac-
tions, steric and depletion forces, coordination bonding, hy-
drophobic forces, electrostatic interactions, hydrogen bond-
ing, !-!staking interactions and solvation and hydration 
forces [20,23]. Strong dipole-dipole interaction with greater 
extent of selectivity and spatial arrangement is important in 
the production of self-assembled structure [24]. 
 Most common stimuli directing self-assembly include 
pH, light, ionic strength, solvent polarity, temperature, elec-
tromagnetic radiation, or redox activity that can be used for 
spatial distribution of the particles, either via straight forward 
intermolecular interactions or on top of predefined templates. 
2.1. Hydrophobic Effect 
 The hydrophobic effect is most important among vari-
ous non-covalent interactions in the self-assembly process. 
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In general, the building blocks in self-assembly are am-
phiphilic molecules, comprising many synthetic building 
blocks and biomolecules like proteins and lipids. As both 
polar and non-polar regions coexist, the self-assembly of 
amphiphilic molecules can be readily aided by thermody-
namics. 
2.2. Electrostatic Interactions 
 Electrostatic forces like attraction and repulsion between 
ions, charged atoms or molecules also have a strong effect on 
self-assembly. Anionic proteins, genes and cationic polymers 
interact with each other through electrostatic interactions and 
form stable nanoparticles in aqueous solutions like in the 
case of a water-soluble cationic conjugated polymer that can 
bind to DNA by both electrostatic interactions and hydro-
phobic effect. 
2.3. Hydrogen Bond 
 An electrostatic attraction between Hydrogen atom and a 
highly electronegative atom such as Nitrogen, Oxygen, or 
Fluorine is commonly known as hydrogen bonding. Hydro-
gen bonding has a vital part in the formulation of polymer 
sciences, affecting their morphological properties. Alteration 
in hydrogen bonding changes the structural properties of 
polymers and affects degree of polymerization. Hydrogen 
bonding can exist both in between molecules and within 
molecules. Hydrogen bonding is  pervasive in inorganic 
molecules as well as organic molecules. For example, the 
nano particulates formed by peptides, hydrogen bond exists 
between the amides and carbonyls in the backbone of sheets 
that are formed by the self-assembly and increases the stabil-
ity of the formulation (Table 1). 
3. SELF-ASSEMBLED NANOSTRUCTURES 
3.1. Polymeric Nanostructures 
 In the field of drug delivery, polymeric nanostructures are 
the prime area of interest for the formulation scientistsfor a 
long time. It has been established that the nanocarriers fabri-
cated by polymers can improve the solubility of hydrophobic 
drugs and reduce the drug associated toxicities on non-target 
tissues. These formulations can also prolong the circulation 
time of drugs in systemic circulation and improve therapeutic 
efficiency. The polymers commonly adopted in the develop-
ment of nanoformulations are usually nontoxic and biocom-
patible [25]. Chitosan, heparin and dextran are the few exam-
ples of natural polymers that have been well investigated for 
drug delivery [26-28]. Polyesters, polycarbonates, polyamides, 
and polyphosphazenes are among the commonly used synthet-
ic polymers [29-32]. Along with the improvement of solubility 
of various hydrophobic drugs, these self-assembled nanoparti-
cles of polymeric amphiphiles can preferentially accumulate in 
solid tumours by enhanced permeability and retention (EPR) 
effect when administered into the systemic circulation [33]. 
This section of the article will mainly focus on various poly-
meric nanostructures in the improvement of efficacy and safe-
ty in the delivery of pharmaceuticals.  
Table 1. Classification of self-assembled nanoparticulates. 





o Stimulus sensitive polymeric nanoparticulates	  
Lipid based nanoparticulates o Liposomes 
o Solid lipid nanoparticles 
o Niosomes 
Carbon based nanoparticulates o Graphene 
o Carbon nanotubes 
o Fullerenes 
Ceramic nanoparticulates o Silica 
o Calcium phosphate 
o Alumina 
o Titania 




o Super paramagnetic oxides 
Biologicals based nanoparticulates o Peptide based 
o Nucleic acid based 
o Viral capsid based 
Miscellaneous o Drug Based 
 
4    Current Drug Delivery, 2020, Vol. 17, No. 0 Varma et al. 
3.1.1. Self-assembled Polymeric Micelles 
 Delivery of hydrophobic drugs has been targeted through 
amphiphilic micelles for decades because of the advantages 
of solubilising capacity, stability within the systemic circula-
tion and capability of high drug loading [34]. Further, small 
size, unique core shell structure, and changeable surface 
chemistry made them a popular nanostructure in the field of 
nanotechnology. These micelles and/or liposomes mimic 
structures of the bio-membrane of human body, and can also 
contain macromolecules with both hydrophobic and hydro-
philic regions [35]. It is known that the amphiphilic poly-
mers at above critical micelle concentration (CMC) and crit-
ical micelle temperature (CMT), spontaneously form na-
nosized aggregates in the aqueous medium. The research on 
polymeric micelles has crossed the level of bench level re-
search and reached the bedside of the patients. Most of the 
polymeric micelles in clinical trials consist of poly(ethylene 
glycol) and its derivatives [36, 37]. These polymeric micelles 
are useful to deliver therapeutics and peptides; however, the 
above-mentioned polymers are unable to formulate formula-
tions for gene delivery. Alternatively, polyamidoamine 
(PAMAM) dendrimers, polyethylenimine and reducible poly 
(oligo-D-arginine) have been used in the delivery of genetic 
materials [38]. Hydrophobic modifications of PAMAM den-
drimers and polyethylenimine has found to improve gene 
delivery [39]. It has been established that hydrophobic modi-
fication of the PAMAM dendrimers and polyethylenimine 
form micelles in the aqueous environment and thus found to 
be useful for delivering hydrophobic drugs [39, 40]. Con-
versely, amphiphilic di-block (hydrophilic-hydrophobic) or 
tri-block (hydrophilic-hydrophobic-hydrophilic) copolymers 
are also employed in the preparation of self-assembled pol-
ymer micelles. Most of the self-assembled micelles of am-
phiphilic block copolymers have a diameter of 10 to 80 nm 
with a hydrophilic shell and a hydrophobic core which is a 
steric barrier for aggregation and prevent binding to proteins 
and opsonisation during the systemic administration which 
blocks the RES uptake (Fig. 2). Poly(ethylene glycol) and 
poly(ethylene oxide) are FDA approved and mostly used 
hydrophilic blocks [41]. Examples of block copolymers poly 
(L-amino acids), biodegradable poly(esters) e.g. 
poly(glycolic acid), poly(D-lactic acid), poly(D,L-lactic ac-
id), copolymers of lactide/glycolide, and poly( -
caprolactone), phospholipids/long chain fatty acids; and pol-
ypropylene oxide(pluronics / poloxamers) are the examples 
for tri-block-copolymers [42]. 
3.1.2. Self-Assembled Polymeric Vesicles 
 Hydrophilic and hydrophobic parts of the amphiphilic 
polymers form special alignment to create a pluriform ag-
gregate [43]. Thus, like self-assembled polymeric micelles, 
such polymers can also tend to form polymeric vesicles. 
Such vesicles can be formed either by the self-assembly of 
polymers or from the polymerization of monomers following 
self-assembly. Block copolymers, random graft copolymers, 
etc. form polymeric vesicles. These self-assembled vesicles 
are nowadays at the leading nanotechnological tool with lim-
itless possible uses, ranging from biomedical application to 
enzymatic reactors of nano-range [44].  
 Polymer self-assembly into vesicles is not a spontaneous 
process due to steric or ionic repulsion between head groups 
and normally requires application of external energy, such as 
probe sonication [45]. Minimum interfacial energy aids the 
formation of a closed spherical bilayered. In general, lesser 
hydrophobic amphiphiles form micelles, while amphiphiles 
of intermediate hydrophobicity form vesicles. The self-
assembly of polymers into vesicles depends on the hydro-
phobic-lipophilic balance of polymers as seen in liposomes 
and niosomes. Few polymer specific factors, like the degree 
of polymerization, flexibility of the hydrophobic block in 
block copolymers have an impact on the ability to form vesi-
cles. High degree of polymerization prevents vesicle for-
mation. Polymeric vesicles possess good physical stability 
and are usually less susceptible to degradation by organic 
solvents and soluble surfactants, and are frequently less per-
meable to hydrophilic solutes, compared with vesicles pre-
pared from low molecular weight amphiphiles [46]. 
 The vesicles formed by the block copolymers possess 
superior physical and mechanical properties compared to the 
lipid‐based vesicles [44]. Vesicles with higher molecular 
weight copolymers had shown an increase in robustness of 
the vesicle due to the increase in thickness of the vesicle 
membrane, which further leads to an increase in greater 
bending rigidities [44, 47]. However, it has been established 
that the membrane elasticity of phospholipid vesicles does 
not depend on the molecular weight [44]. Similarly, 
 
Fig. (2). Self-assembly of amphiphilic block copolymer in aqueous media. (A higher resolution / colour version of this figure is available in 
the electronic copy of the article). 
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polymerizable vesicles forming monomers are used to pre-
pare self-assembling nano-particulates. The advantages of 
this system are that they can be prepared and stored as dry 
powders and can be easily re-dispersed in the aqueous media 
to form 50-100 nm particles with less leaky, and thermosta-
ble properties [48]. 
3.1.3. Polymeric Nanogels 
 Application of nanogels has been extended towards sev-
eral fields of research, such as diagnostic, sensing, bioengi-
neering and most importantly, drug delivery [49]. Polymeric 
nanogels are usually nanosized polymer networks, with an 
affinity towards aqueous media to imbibe, inertness in sys-
temic circulation, superior colloidal stability, and suitable for 
bulky drug incorporation [50]. Polymeric nanomicelles and 
nano vesicles carry a main disadvantage i.e. they are stable 
only above the critical micelle concentration (CMC), but 
below CMC they tend to dissociate into single polymer 
chains and have a loose drug carrying capacity. So to avoid 
this dissociation of the self-assembled nanostructures, link-
ing the polymers to obtain nanogels which are more stable 
has become an effective approach in drug delivery system 
[51]. Another important advantage of the polymeric nanogels 
over the standard nanocarriers is the increased encapsulation 
of the therapeutics and offering of three dimensional micro-
environment for the application in different therapeutic pur-
poses, including tissue engineering [52].  
 This self-assembly nanogels preparation method is exten-
sively useful where the controlled collection of amphiphilic 
or hydrophilic polymers forms the formulation due to the 
physicochemical interactions, such as electrostatic interac-
tions, hydrophobic interactions, stereo-complexation or su-
pramolecular chemistry and hydrogen bonding [42]. 
Kabanov and Vinogradov reported the use of labile disulfide 
bonds of cystamine as a biodegradable cross-linker through 
electrostatic interactions. Thus, besides the physical interac-
tions between the molecules, a covalent cross-linking be-
tween the cross linking polymeric chains was utilized in the 
formation of a thermodynamically stable nanogel [53]. Al-
ternatively, as described by Akiyoshi and  colleagues, the 
hydrophobic interaction of cholesterol modified pullulan and 
insulin forms the nanosized hydrogels [54]. The presence of 
cross-linkers impact mainly on the swelling characteristic, 
morphology and pore size of the nanogels, which ultimately 
affect the release kinetics of the incorporated therapeutic 
entities. Thus, to achieve controlled delivery of the entrapped 
therapeutics, various stimulus responsive polymers are intro-
duced where the polymers are cleavable under redox envi-
ronment, pH change, enzyme, light, etc. Zhao et al. reported 
the formation of thermal- and photo-responsive core-shell 
nanogels via temperature sensitive self-assembly in aqueous 
solution of a double-hydrophilic block copolymer, followed 
by reversible photo-dimerization and photo-cleavage [55]. 
3.1.4. Polymeric Nanocapsules 
 Nanocapsules are sub-micrometer ranged hollow spheri-
cal structures which are composed of polymer shell with 
inner hollow space. These nanocapsules can be incorporated 
to improve the oral bioavailability of proteins and peptides. 
Encapsulation of therapeutic agents in nanocapsules is pro-
tected from degradation in the external adverse environment, 
at the same time it could provide a controlled release profile 
of the entrapped drug, reduces systemic toxicity, and mask 
the unpleasant taste [56]. Various methods have been adopt-
ed to formulate nanocapsules where the polymer shell is 
formed first over a template particle which is subsequently 
removed to obtain the inner hollow space [42].  
 Layer-by-layer self-assembly method is a popular method 
to formulate the outer polymeric shell on template particle. 
This was executed by charge surface of polyelectrolyte self-
assemblies where the oppositely charged polyelectrolytes in 
a solution deposited over the template particle in a layer-by-
layer pattern. The polymeric layer is formed on the template 
surface by electrostatic interactions. This deposition of the 
polyelectrolytes can be controlled to maintain the thickness 
of the polymeric cells [57]. Commonly used template parti-
cle for layer-by-layer electrostatic self-assembly is obtained 
by incorporating functionalized polystyrene latex particles. 
As the charge on the surface changes over the absorption of 
one electrolyte, another oppositely charged group of poly-
electrolytes is then absorbed to get the layer-by-layer pattern. 
For example, low molecular weight polyglutamic acid and 
chitosan were alternatively assembled over sulfonated poly-
styrene beads by Dash and teams [58]. 
3.1.5. Polymeric Dendrimers 
 Dendrimers are three-dimensional, hyper branched spher-
ical nanopolymeric structures (Fig 3), which have been suc-
cessfully incorporated in various fields of therapy [59, 60]. 
The major advantages of the dendritic deliveries include the 
nano size range, low polydispersity index, controlled molec-
ular structure, modifiable surface with multiple functional 
groups, and ability to incorporate hydrophilic and lipophillic 
therapeutic agents within the interior cavities or outer surface 
of the three dimensional structure [4, 61]. These dendritic 
structures are mostly synthesized by the convergent and the 
divergent methods, where the growth of the molecules starts 
from its periphery towards the core in convergent method, 
but the growth of the molecule in divergent method is initiat-
ed from the core, proceeds from the core towards periphery 
[62-64]. These two stepwise methods are tedious and time-
consuming because of several protection-deprotection and 
extensive purification steps. However, the divergent method 
is considered to be suitable for large scale synthesis and 
preparation of higher generation dendrimers [42, 65]. 
3.2. Lipid Based Nanoparticulates 
3.2.1. Self-assembled Liposomal Nanostructures 
 Nanostructures fabricated with liposomes are the first 
drug delivery system on the nanoscale to make the transition 
from concept to clinical application. Liposomes incorporate 
both hydrophilic and hydrophobic materials in their respec-
tive compartments by nature. Along with this unique ad-
vantage, biocompatibility and biodegradability are the added 
advantages that make liposomes attractive as drug delivery 
vehicles. Liposomes can accumulate at sites with high vascu-
lar permeability when their average diameter is in the ultra-
filterable range (<200 nm). Liposomes, in general, are thin, 
fragile, and thus not stable and also have limited use due to 
low encapsulation efficiency, rapid leakage and poor storage 
stability (Fig. 4a) [13, 66, 67]. 
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Fig. (3). Molecular arrangement of dendrimer. (A higher resolution / 
colour version of this figure is available in the electronic copy of the 
article). 
 Molecular self-assembly of the liposomal components 
forms the liposomal delivery by the non-covalent interac-
tions. Spontaneous association of the amphiphilic liposomal 
components results in isolation of lipophilic fractions in an 
aqueous media, leading to the formation of a well-defined 
and stable supramolecular structure [68, 69]. This is consid-
ered to be an important approach for the fabrication of bio-
materials [16, 70]. This could not be achieved by the bottom-
up process where contact between the required building 
blocks and obtaining the desired assembly is always chal-
lenging. Such control over self-assembly process could be 
achieved using electro spraying, a hydrodynamic atomization 
approach [70-72]. This process utilizes electrical energy to 
vaporize the solvent from a polymer solution; it is a top-
down process which ultimately results in solid dispersion for 
the formation of submicron-ranged units. Electro spinning 
technique is also used to yield nanoscale fibres, similar to 
electro spaying, and thereby forms nanoscale objects from 
different components [73]. 
3.2.2. Self-assembled Niosomes 
 Niosomes are synthesized by the self-assembly of non-
ionic surfactants, often contains dicetyl phosphate, and cho-
lesterol along with the surfactant. Associated properties and 
structural architecture of niosomes are  similarto liposomal 
deliveries or biological complements comprising of biologi-
cal phospholipids [74, 75]. The self-assembly of non-ionic 
surfactants into niosomes is dependent on the hydrophilic-
hydrophobic balance of the surfactant and a CPP between 
0.5-10 enables niosomal self-assembly [76, 77]. Cholesterol 
component in the niosomes generally serves as a membrane 
stabilizer. Development of niosomal formulation in the la-
boratory is performed by mixing  two liquid phases in a con-
tainer for their spontaneous self-assembly to form the desired 
niosomes. Such self-assembly in the container could not con-
trol the mechanical and chemical environments, which re-
sults in niosomes with high polydispersity index [74, 78]. 
This scenario instigates the use of size-altering processes, 
such as sonication or extrusion, to obtain more homogenous 
niosomal particles.  
3.2.3. Self-assembled Lipid Polymer Hybrid Nanoparticle 
 Self-assembly of lipid polymer hybrid nanoparticle pro-
vides a sturdy drug delivery platform with high drug loading 
efficiency, sonorous and sustained drug release behaviour, 
superior stability profile and promising targeting of various 
cells and tissue (Fig. 4b) [79, 80]. The structure of lipid-
polymer-lipid hybrid nanostructure also consists of a charged 
hollow shell, a middle polymeric hydrophobic layer, and a 
neutral lipid outer layer. These are usually formulated by 
double-emulsion solvent evaporation technique and self-
assembly method. Sometimes, the outer layer is modified 
with PEG to avoid immunological recognition of the devel-
oped nanoparticle. Incorporation of PEG could also help in 
particle stability in systemic circulation, controls the degra-
dation of polymer and ultimately, release of an incorporated 
drug. The middle layer of the polymer also controls the en-
trapped therapeutic molecules and serves to deliver hydro-
phobic therapeutics. The inner hollow core also serves as 
carrier for the therapeutic agents [79]. 
3.3. Carbon Based Nanoparticulates 
3.3.1. Graphene 
 Carbon atoms patterned a single layer in a hexagonal 
lattice, i.e., graphene has gained potential interest in the field 
of energy storage devices, catalysis, sensors, and environ-
mental field (Fig. 5A) [81, 82]. Graphene has honeycomb 
like structure and follow sp2 hybridised lattice having zero 
energy band gap and characteristics like wider surface area, 
more conductivity and effective mechanical and chemical 
stability. Due to these characteristics, graphene serves as a 
suitable substrate for research purpose like in fuel cell catal-
ysis, drug delivery and biosensing, etc. [83, 84]. Such atom-
ic-scale honeycomb lattice offers good biocompatibility and 
has low cytotoxicity with excellent electronic, thermal, and 
mechanical properties. Thus, the two-dimensional structures 
of graphene and its functional derivatives are used well as 
building blocks for functional self-assembled carbon-based 
nanostructures. Among the functionalized structures, 1-
 
Fig. (4). Self-assembled lipid based nanostructures, A. Liposomes, and B. Lipid polymer hybrid nanoparticle. (A higher resolution / colour 
version of this figure is available in the electronic copy of the article). 
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dimensional tube tube-in-tube nanostructures [85, 86], 2-
dimensional graphene film [87] and 3-dimensional gra-
phene/polymer composites [88, 89] are widely researched 
worldwide. The presence of numerous oxygen containing 
functional groups on graphene oxide sheets make them easi-
ly processable and soluble for research. Worldwide research 
on these graphene sheets leads to the innovation of novel 
graphene-based materials, such as nanoparticle decorated 2-
dimensional graphene sheets [90,91]. Alternatively, 3-
dimensional graphene networks were developed by Chen and 
team with magnetic nanoparticles [92, 93]. Graphene has 
lipophilic property and does not dissolve in aqueous solvent,  
as it forms coagulates by van der waals interaction. Gra-
phene products also have greater efficacy as compared to 
various types of carbon nanoparticles such as carbon nano-
tubes and fullerene. PEGylated conjugated graphene func-
tionalized moieties were synthesised with rendering high 
solubility in aqueous based solutions for enhancing solubility 
of water insoluble compounds. Non-covalently bonded as-
semblies of graphene were formulated with cyclodextrins by 
entrapping drug as host and delivery to the specific sites. But 
graphene based self-assembly systems counterfeit with the 
issue of unknown mechanism for metabolic pathway fol-
lowed for itself and its metabolites.  
 
Fig. (5). Self-assembled carbon nanostructures, A. Graphene, B. 
Carbon nanotube, C. Fullerene. (A higher resolution / colour version 
of this figure is available in the electronic copy of the article). 
 
3.3.2. Carbon Nanotubes 
 Carbon nanotubes (CNTs) (Fig. 5B) are carbon made 
tube shaped materials  that look like a chicken roll with con-
tinuous hexagonal mesh and presence of graphene at the 
peaks of hexagonal structures [94]. Carbon nanotubes mainly 
belong to fullerene family, it is cylindrical in shape and gen-
erally one end is open but, in some cases, it is closed with 
full fullerene caps. The size of carbon nanotubes is from few 
nanometers to several micrometers (its length is approx. 
50,000 times smaller than the width of normal human hairs) 
[94]. These are similar to graphene but have potential ad-
vantages over other nanocarriers because of its unique prop-
erties of large thermal conductivity, high electrical conduc-
tivity and mechanical properties [95]. Further, for drug de-
livery tools, small drug molecules can be loaded in their 
large inner hollow space of CNTs, whereas proteins and 
genes can be loaded on their outer surface by chemical modi-
fication [23]. Kim and colleagues had reported the self-
assembly of a drug-peptide conjugate into a well-defined 
nanotube to obtain increased resistance against hydrolytic 
deactivation of the entrapped components and to get superior 
antitumor response of the incorporated drugs [96].  
 Carbon nanotubes family belongs  to graphite and fuller-
ene class; it is new elements of carbon allotrope groups. Sim-
ilarly, super aligned CNTs are also used to formulate self-
assembled carbon nano-sponge utilizing the compact, well-
aligned, and clean surface properties of the super aligned 
CNTs [95]. A continuous and monolithic 3-dimensional 
network of the super aligned CNTs was formed by ultrasoni-
cation and co-deposition method. This network is only pos-
sible with super aligned CNTs because of the strong interac-
tion between the nanotube molecules, however, this is not 
applicable to ordinary CNTs [95]. 
3.3.3. Fullerene 
 Nanomolecular carbon cages (Fig. 5C), fullerenes are a 
platform for the delivery of therapeutics or imaging agents. 
Fullerene basic structure contains carbon atoms in different 
forms such as hollow sphere and tubes. Fullerene has C60 
structure, symmetric molecule with 20 hexagons and 12 pen-
tagons, all the rings of fullerene are fused with conjugated 
double bond. They have tremendous conjugation but chemi-
cally and physically they act as electron scarce alkenes [97, 
98]. Basic functional mode of fullerenes includes the role  of 
drug delivery scaffold or vector, where the biologically ac-
tive moiety may or may not be linked with the fullerene [97]. 
A protein and fullerene co-assembly has been reported by 
Kim and colleagues where the compatible interaction result-
ed via non-polar interaction between the two structures [99]. 
Such devices with conjugated polymers have also gained 
potential research interest in current years because of their 
fascinating properties, including flexibility of structure, 
lightweight, and low-cost production [98]. Fullerene based 
buckysomes self-assembling system was synthesised in size 
range of 100-200 nm. These buckysomes based self-
assemblies were explored for delivery of water-insoluble 
drugs especially anti-cancer drugs. Buckysomes bulky struc-
tures were feasible for encapsulating bulkier drug molecules. 
Fullerene  can get entrapped within lipophilic cavity of HIV 
protease and inhibit the overindulgence amount of sub-
strate present on enzyme catalytic site. Fullerenes have 
also property of radical scavengers and antioxidants, when 
fullerene is bare under light it forms singlet oxygen. In 
pharmaceutical industry fullerenes have wide application 
in drug delivery system and as a carrier in gene delivery. 
3.4. Ceramic Nanostructures 
 Inorganic compounds like silica, calcium phosphate, 
alumina, Titania, etc. can be fabricated into porous 
nanostructures which are biocompatible. It includes mesopo-
rous silica nanostructures and calcium phosphate-based 
nanostructures and is recently applied nanostructured assem-
blies in research. 
3.4.1. Mesoporous Silica Nanostructures 
 Mesoporous silica nanoparticle has a solid rigid outline 
with high specific surface area, adjustable pore size and di-
ameter, and versatile functionalization, which helps to attach 
different functional groups of drug molecule to targeted site. 
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Chemically MSN is honeycomb like structure with an active 
surface. MSNs are wide spread due to its higher drug loading 
tendency and fewer side effects, the silica present in MSNs 
has more biocompatibility than other metal oxides such as 
titanium and iron oxides. Mechanism of generation of drug 
loaded silica based mesoporous nanoparticles is simply by 
diffusion. Drug molecules are suspended in a solvent along 
with mesoporous silica or melting drug liquid is poured on 
silica. Application of concentration gradient allows the diffu-
sion of drug molecules into pore. The mesoporous structure 
of silica has an exclusive property specially its greater drug 
loading capacity and strong Si-O bonds of mesoporous silica 
nanoparticle provide stability and prevent it from degrada-
tion. Hence, MSNs are more stable than other nanoparticu-
lates formulations such as liposomes, niosomes and den-
drimers [100]. A wide variety of drugs have been loaded or 
covalently grafted in it. Folate, mannose, galactose functional-
ized MSNs have been reported to induce higher cytotoxicity in 
cancer cells. The mesoporous nanoparticulates are formulated 
either by simple sol gel method or by spray dry technique 
(Fig. 6).  
3.4.2. Calcium Phosphate Nanostructures 
 Hydroxyapatite and tricalcium phosphates are the com-
pounds which have calcium phosphate, chemical similarity to 
the bone and are biocompatible. Along with biocompatibility 
it also offers controlled release and has variable surface charge 
density. Scientists successfully synthesised mono dispersive 
nanoparticles of Calcium phosphate surrounded by hydro-
philic polymeric chains. Calcium phosphate nanoparticles 
(CPNPs) are used for DNA transfection because of their good 
penetration through cell membrane, stay and bound with trans-
fecting DNA inside the cell hence, protecting the DNA from 
lysosomal enzyme so the DNA is stably retained in cell cyto-
sol until it translocates into the nucleus. CPNPs are biocom-
patible in nature because bone and teeth contain calcium 
phosphate and tend to bind with DNA hence it is recognised 
under second generation vector for proficient delivery of gene 
within the cell. Calcium phosphate nanoparticles are multi-
layer shell nanoparticles which include calcium phosphate 
core followed by DNA layer and then additionally pursued by 
calcium phosphate shell. This type of multilayer shell shield 
the DNA from degradation by nuclease/lysosome. CPNPs are 
prepared by various methods such as co-precipitation, sol-gel 
synthesis, electrodeposition and microemulsion [101].  
3.5. Biologicals Based Nanoparticulates 
3.5.1. Peptides-based Nanostructures 
 Peptides have advantages like biocompatibility, biodeg-
radability, low cost, tunable bioactivity, high drug loading 
capacities, chemical diversity, site specific targeting and 
stimuli responsive drug delivery at disease sites. Various 
nano-based structures like nanoparticles, nanotubes, nano-
fibers, and hydrogels have been synthesized [14]. Naturally 
occurring self-assembly motifs present in proteins such as α-
helices, β-sheets and coiled-coils can be used to drive the 
self-assembly process, peptides can form well-defined 
nanostructures of any size and shape. Additionally peptide 
functionalization can easily be performed by introducing 
various compounds to the peptide structure. Self-assembled 
peptides (SAPs) are the smart delivery systems with an ap-
proach for intracellular uptake, targeting, controlled release 
and enhanced biological functionality. SAPs might interact 
with protein assemblies or protein present in certain cells to 
strategically target and manipulate the fate of cell. SAPs 
based delivery systems can be formulated in the form of 
nanotubes, vesicles and hydrogels for delivering the anti-
cancer moieties to specific cancerous site.  
3.5.2. Nucleic Acids Based Nanostructures 
 Preparation of cationic lipid-nucleic acid nanoparticle 
from a liquid monophase containing water and a water mis-
cible organic solvent where both lipid and DNA components 
are separately soluble prior to their combination was report-
ed. Upon removal of the organic solvents, stable and homo-
geneously dispersed (70-100 nm) lipid-nucleic acid nanopar-
ticles (Genospheres) were formed [102]. Nucleic acid is an 
extensively used bio-material in nanoformulations because it 
holds mainly carbonyl and amino moiety on the surface of 
nucleoside chain and this helps to coordinate with metal ion. 
The negatively charged phosphate group present on surface 
retard the irreversible coagulation of nanoparticles and gath-
er metal ion alongside the nucleic acid framework through 
electrostatic interaction. Nucleic acid has the ability to form 
stable and adaptable metal nanoparticles. In current scenario, 
nucleic acid based nanostructure sets up an enormous poten-
tial in the field of nano-biotechnology particularly in drug 
delivery and cellular imaging. For example, DNA block co-
 
Fig. (6). Self-assembled mesoporous silica nanoparticles. (A higher resolution / colour version of this figure is available in the electronic copy 
of the article). 
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polymer micelles play a vital role in cancer nanotechnology 
and in novel drug delivery system to deliver drug at specific 
site [103]. Poly (ethylene imine) PEI is most widely used 
polymer in nucleic acid based nanostructure drug delivery 
[104]. 
3.6. Miscellaneous 
3.6.1. Drug-based Nanostructures 
 Some small molecule drugs have the property to show 
reversible self-assembly behaviour, which can be used to 
form supramolecular nanostructures of well-defined size and 
shape. Amphiphilic prodrugs can be synthesised by conju-
gating hydrophilic polymers with hydrophobic drugs and 
these prodrugs can be used to prepare stable nanostructures 
spontaneously by self-assembly. In this way, a self-delivery 
system can be obtained and it can provide a sustained drug 
release [105,106]. 
3.6.2. Inorganic Metal Nanostructures 
 Metallic nanoparticles, such as gold, silver, gadolinium, 
and iron oxide are the inorganic metal nano structures which 
are under study for drug delivery and targeting. Gold nano-
particles (AuNPs) gain much more interest in this era due to 
their properties like excellent biocompatibility, higher stabil-
ity inside the cell, simple surface modification and flippant 
synthesis process. Gold nanoparticles of different shapes 
such as rod shape, dumbbells and dog bone shape are formu-
lated via seed mediated method. Change in pH and presence 
of silver (Ag+) ion affect processing of gold (Au) nanoparti-
cles [107] (Fig. 7). 
 
Fig. (7). Self-assembled gold nanoparticles. (A higher resolution / 
colour version of this figure is available in the electronic copy of the 
article). 
 
4. FUTURE PERSPECTIVES 
 This review discussed various examples related clearly to 
the significant advances related to the field of nano based 
drug delivery and effectiveness in relation to self-assembly 
based drug delivery systems. Examples cover both temporal 
and spatial targeting of self-assembled nanovectors. Future 
challenge is combining all the features of above discussed 
self-assembled systems into one system and achieving par-
ticular needs with further attachment with special ligands for 
active targeting or pulsatile release behaviour. These self-
assembled nanovectors can be employed for therapeutic in-
tervention in cancer, anti-retroviral therapy, gene therapy, 
antibiotic therapy with better potential. Further, the potential 
of these self-assembled drug delivery systems is not fully 
explored and limited to application in auxiliary moieties. 
Recent development in self-assembling drug delivery sys-
tems will open the doors to new ways of future drug delivery 
and exciting for formulation scientists.  
CONCLUSION 
 Self-assembled nanoparticles have a tendency to form 
well defined structure driven by various non-covalent inter-
action like van der-waals interaction, hydrophobic forces, 
electrostatic interaction, hydrogen bonding and π-π staking 
interaction. In recent research it was found that self-
assembled nanoparticles synthesized by using several bio-
materials such as carbohydrates, peptide and protein play an 
important role in siRNA and gene delivery. Self-assembled 
nanostructure could serve a wide variety of functions includ-
ing controlled and targeted drug delivery, long circulation, 
reduce side effects, and provide stability to formulation, en-
hance penetration and due to their smaller size allow the de-
livery via intravenous routes. However, formulation scien-
tists are still facing lots of hurdles in delivering a drug 
through self-assembled nano formulation because of their 
stability issue, and molecular weight (in case of protein and 
peptide drugs). In recent scenario, self-assembled nanoparti-
cles have the potential for site specific targeting by minimiz-
ing peripheral tissue toxicity hence, boost drug delivery sys-
tems.  
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